These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11412989)

  • 21. The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Hamon M; De Benedetti PG; Menziani MC
    Curr Top Med Chem; 2002 Jun; 2(6):599-624. PubMed ID: 12052196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P; Subra G; Verdie P; Gabzdyl E; Bojarski AJ; Duszyńska B; Martinez J; Pawłowski M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4827-31. PubMed ID: 19560916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
    Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric interactions among agonists and antagonists at 5-hydroxytryptamine3 receptors.
    Bonhaus DW; Stefanich E; Loury DN; Hsu SA; Eglen RM; Wong EH
    J Neurochem; 1995 Jul; 65(1):104-10. PubMed ID: 7790853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Methylene Bridge" to 5-HT
    Abdelkhalek AS; Alley GS; Alwassil OI; Khatri S; Mosier PD; Nyce HL; White MM; Schulte MK; Dukat M
    ACS Chem Neurosci; 2019 Mar; 10(3):1380-1389. PubMed ID: 30375852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrostatic potential surfaces of 5-HT(3)R agonists suggest accessory cation-pi site adjacent to agonist binding domain.
    Parihar HS; Kirschbaum KS
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2743-7. PubMed ID: 12217367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
    Rahman AA; Daoud MK; Dukat M; Herrick-Davis K; Purohit A; Teitler M; do Amaral AT; Malvezzi A; Glennon RA
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1119-23. PubMed ID: 12643925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
    Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
    Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
    Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
    Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
    López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
    Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superagonist, Full Agonist, Partial Agonist, and Antagonist Actions of Arylguanidines at 5-Hydroxytryptamine-3 (5-HT
    Alix K; Khatri S; Mosier PD; Casterlow S; Yan D; Nyce HL; White MM; Schulte MK; Dukat M
    ACS Chem Neurosci; 2016 Nov; 7(11):1565-1574. PubMed ID: 27533595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
    Lummis SC; Baker J
    Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
    Ito C; Isobe Y; Tsuchida K; Higuchi S
    Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
    J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT(7) antagonists.
    Rudolph DA; Dvorak CA; Dvorak L; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2011 Jan; 21(1):42-4. PubMed ID: 21159507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.